×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
JBIO – jade biosciences, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
JBIO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/18
02:00 pm
jbio
What Makes Jade Biosciences, Inc. (JBIO) a New Buy Stock [Yahoo! Finance]
Medium
Report
What Makes Jade Biosciences, Inc. (JBIO) a New Buy Stock [Yahoo! Finance]
11/18
09:14 am
jbio
Jade Biosciences (NASDAQ:JBIO) had its price target raised by analysts at Guggenheim from $14.00 to $17.00. They now have a "buy" rating on the stock.
Medium
Report
Jade Biosciences (NASDAQ:JBIO) had its price target raised by analysts at Guggenheim from $14.00 to $17.00. They now have a "buy" rating on the stock.
11/15
01:42 am
jbio
Jade Biosciences (NASDAQ:JBIO) was upgraded by analysts at Wall Street Z
High
Report
Jade Biosciences (NASDAQ:JBIO) was upgraded by analysts at Wall Street Z
11/8
11:15 am
jbio
Jade Biosciences Presents New Data Demonstrating a Favorable Preclinical Safety Profile of JADE101 and a Translational Analysis of APRIL Mediated Biomarker Responses at the American Society of Nephrology Kidney Week 2025 [Yahoo! Finance]
Medium
Report
Jade Biosciences Presents New Data Demonstrating a Favorable Preclinical Safety Profile of JADE101 and a Translational Analysis of APRIL Mediated Biomarker Responses at the American Society of Nephrology Kidney Week 2025 [Yahoo! Finance]
11/8
11:00 am
jbio
Jade Biosciences Presents New Data Demonstrating a Favorable Preclinical Safety Profile of JADE101 and a Translational Analysis of APRIL Mediated Biomarker Responses at the American Society of Nephrology Kidney Week 2025
Medium
Report
Jade Biosciences Presents New Data Demonstrating a Favorable Preclinical Safety Profile of JADE101 and a Translational Analysis of APRIL Mediated Biomarker Responses at the American Society of Nephrology Kidney Week 2025
11/3
07:00 am
jbio
Jade Biosciences to Participate in Upcoming Conferences
Medium
Report
Jade Biosciences to Participate in Upcoming Conferences
10/17
04:20 pm
jbio
Jade Biosciences Announces New Data Presentations for JADE101 at the American Society of Nephrology Kidney Week 2025 [Yahoo! Finance]
Medium
Report
Jade Biosciences Announces New Data Presentations for JADE101 at the American Society of Nephrology Kidney Week 2025 [Yahoo! Finance]
10/17
04:05 pm
jbio
Jade Biosciences Announces New Data Presentations for JADE101 at the American Society of Nephrology Kidney Week 2025
Medium
Report
Jade Biosciences Announces New Data Presentations for JADE101 at the American Society of Nephrology Kidney Week 2025
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/14
04:36 pm
jbio
Form SCHEDULE 13G/A Jade Biosciences, Inc. Filed by: Frazier Life Sciences Public Fund, L.P.
High
Report
Form SCHEDULE 13G/A Jade Biosciences, Inc. Filed by: Frazier Life Sciences Public Fund, L.P.
11/14
04:13 pm
jbio
Form S-1 Jade Biosciences, Inc.
High
Report
Form S-1 Jade Biosciences, Inc.
11/14
08:18 am
jbio
Form SCHEDULE 13G/A Jade Biosciences, Inc. Filed by: Deep Track Capital, LP
High
Report
Form SCHEDULE 13G/A Jade Biosciences, Inc. Filed by: Deep Track Capital, LP
11/14
07:14 am
jbio
Form 10-Q Jade Biosciences, Inc. For: Sep 30
High
Report
Form 10-Q Jade Biosciences, Inc. For: Sep 30
11/14
07:01 am
jbio
Form 8-K Jade Biosciences, Inc. For: Nov 13
High
Report
Form 8-K Jade Biosciences, Inc. For: Nov 13
10/17
06:42 pm
jbio
Form SCHEDULE 13G/A Jade Biosciences, Inc. Filed by: BlackRock, Inc.
Medium
Report
Form SCHEDULE 13G/A Jade Biosciences, Inc. Filed by: BlackRock, Inc.
10/16
07:36 pm
jbio
Form SCHEDULE 13G Jade Biosciences, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Medium
Report
Form SCHEDULE 13G Jade Biosciences, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
10/8
04:15 pm
jbio
Form SCHEDULE 13D/A Jade Biosciences, Inc. Filed by: Fairmount Funds Management LLC
Medium
Report
Form SCHEDULE 13D/A Jade Biosciences, Inc. Filed by: Fairmount Funds Management LLC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: